Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-01-26

Clinical Trial Update: Duloxetine in the Treatment of Stress Urinary Incontinence. [Phase 3]

View source ↗

Summary

This document reports the completion status of a Phase 3 duloxetine trial for stress urinary incontinence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cymbalta (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Urinary Incontinence, Stress | Phase 3 | Status: COMPLETED